153 related articles for article (PubMed ID: 1713056)
21. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
Uchida A
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
[TBL] [Abstract][Full Text] [Related]
22. Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model.
Matsumori A; Crumpacker CS; Abelmann WH
J Am Coll Cardiol; 1987 Jun; 9(6):1320-5. PubMed ID: 3034992
[TBL] [Abstract][Full Text] [Related]
23. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
Christmas SE; Meager A; Moore M
Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha.
Tanaka T; Kanda T; McManus BM; Kanai H; Akiyama H; Sekiguchi K; Yokoyama T; Kurabayashi M
J Mol Cell Cardiol; 2001 Sep; 33(9):1627-35. PubMed ID: 11549342
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines.
Kishimoto C; Takada H; Kawamata H; Umatake M; Ochiai H
J Pharmacol Exp Ther; 2001 Nov; 299(2):645-51. PubMed ID: 11602677
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 secreted from human myxoma reduces murine viral myocarditis.
Kanda T; Sakamoto H; McManus BM; Sakamaki T; Nagai R; Suzuki T; Kobayashi I
Life Sci; 1996; 58(20):1705-12. PubMed ID: 8637394
[TBL] [Abstract][Full Text] [Related]
27. OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer.
Sudo T; Aruga A; Shimizu K; Matsushita N; Takasaki K
Anticancer Res; 2006; 26(6B):4327-33. PubMed ID: 17201151
[TBL] [Abstract][Full Text] [Related]
28. Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression.
Saegusa S; Fei Y; Takahashi T; Sumino H; Moriya J; Kawaura K; Yamakawa J; Itoh T; Morimoto S; Nakahashi T; Iwai K; Matsumoto M; Kanda T
Cardiovasc Drugs Ther; 2007 Jun; 21(3):155-60. PubMed ID: 17484035
[TBL] [Abstract][Full Text] [Related]
29. Cell regulatory and immunorestorative activity of picibanil (OK432).
Chirigos MA; Saito T; Talmadge JE; Budzynski W; Gruys E
Cancer Detect Prev Suppl; 1987; 1():317-28. PubMed ID: 3480058
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Matsumori A; Sasayama S
Eur Heart J; 1995 Dec; 16 Suppl O():140-3. PubMed ID: 8682082
[TBL] [Abstract][Full Text] [Related]
31. Encephalomyocarditis (EMC) virus-induced myocarditis by different virus variants and mouse strains.
Hirasawa K; Han JS; Takeda M; Itagaki S; Doi K
J Vet Med Sci; 1992 Dec; 54(6):1125-9. PubMed ID: 1335759
[TBL] [Abstract][Full Text] [Related]
32. Lessons from animal experiments in myocarditis.
Matsumori A
Herz; 1992 Apr; 17(2):107-11. PubMed ID: 1349548
[TBL] [Abstract][Full Text] [Related]
33. The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells.
Kurosawa S; Harada M; Shinomiya Y; Terao H; Nomoto K
Cancer Immunol Immunother; 1996 Sep; 43(1):31-8. PubMed ID: 8917633
[TBL] [Abstract][Full Text] [Related]
34. An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.
Matsumori A; Kawai C
Circulation; 1982 Jun; 65(6):1230-5. PubMed ID: 6280889
[TBL] [Abstract][Full Text] [Related]
35. Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2.
Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
J Virol; 2001 Feb; 75(3):1294-300. PubMed ID: 11152502
[TBL] [Abstract][Full Text] [Related]
36. Reduced-energy diet improves survival of obese KKAy mice with viral myocarditis: induction of cardiac adiponectin expression.
Kanda T; Saegusa S; Takahashi T; Sumino H; Morimoto S; Nakahashi T; Iwai K; Matsumoto M
Int J Cardiol; 2007 Jul; 119(3):310-8. PubMed ID: 17275107
[TBL] [Abstract][Full Text] [Related]
37. Cellular and molecular bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy.
Seko Y; Yamazaki T; Shinkai Y; Yagita H; Okumura K; Naito S; Imataka K; Fujii J; Yazaki Y
Jpn Circ J; 1992 Oct; 56(10):1062-72. PubMed ID: 1331556
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
Miyamoto T; Matsumori A; Hwang MW; Nishio R; Ito H; Sasayama S
J Am Coll Cardiol; 2001 May; 37(6):1713-8. PubMed ID: 11345389
[TBL] [Abstract][Full Text] [Related]
39. Effects of free immunoglobulin light chains on viral myocarditis.
Matsumori A; Shimada M; Jie X; Higuchi H; Groot Kormelink T; Redegeld FA
Circ Res; 2010 May; 106(9):1533-40. PubMed ID: 20360247
[TBL] [Abstract][Full Text] [Related]
40. The effect of cyclosporine on the immunopathogenesis of viral myocarditis in mice.
Matoba Y; Matsumori A; Okada I; Ohkusa T; Kawai C
Jpn Circ J; 1991 Apr; 55(4):407-16. PubMed ID: 1646340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
